요약정보
CTLA4 protects against maladaptive cytotoxicity during the differentiation of effector and follicular CD4 + T cells.
- Resource Type
- Academic Journal
- Authors
- Hao Y; Centre for Personalised Immunology, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.; Translational Research Unit, The Canberra Hospital, Canberra, ACT, Australia.; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.; Miraghazadeh B; Centre for Personalised Immunology, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.; Translational Research Unit, The Canberra Hospital, Canberra, ACT, Australia.; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.; Chand R; Centre for Personalised Immunology, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.; Translational Research Unit, The Canberra Hospital, Canberra, ACT, Australia.; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.; Davies AR; Centre for Personalised Immunology, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.; Translational Research Unit, The Canberra Hospital, Canberra, ACT, Australia.; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.; Cardinez C; Centre for Personalised Immunology, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.; Translational Research Unit, The Canberra Hospital, Canberra, ACT, Australia.; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.; Kwong K; Centre for Personalised Immunology, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.; Translational Research Unit, The Canberra Hospital, Canberra, ACT, Australia.; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.; Downes MB; Centre for Personalised Immunology, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.; Translational Research Unit, The Canberra Hospital, Canberra, ACT, Australia.; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.; Sweet RA; Centre for Personalised Immunology, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.; Translational Research Unit, The Canberra Hospital, Canberra, ACT, Australia.; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.; Cañete PF; Centre for Personalised Immunology, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.; D'Orsogna LJ; Department of Immunology, Fiona Stanley Hospital, Perth, WA, Australia.; Fulcher DA; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.; Choo S; Department of Immunology, The Royal Children's Hospital, Melbourne, VIC, Australia.; Yip D; Department of Medical Oncology, The Canberra Hospital, Canberra, ACT, Australia.; ANU Medical School, The Australian National University, Canberra, ACT, Australia.; Peters G; Department of Medical Oncology, The Canberra Hospital, Canberra, ACT, Australia.; ANU Medical School, The Australian National University, Canberra, ACT, Australia.; Yip S; NHMRC Clinical Trials Unit, The University of Sydney, Sydney, NSW, Australia.; Witney MJ; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.; Nekrasov M; The ACRF Biomolecular Resource Facility, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.; Feng ZP; ANU Bioinformatics Consultancy, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.; Tscharke DC; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.; Vinuesa CG; Centre for Personalised Immunology, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.; Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.; Cook MC; Centre for Personalised Immunology, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia. mc2386@cam.ac.uk.; Translational Research Unit, The Canberra Hospital, Canberra, ACT, Australia. mc2386@cam.ac.uk.; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia. mc2386@cam.ac.uk.; ANU Medical School, The Australian National University, Canberra, ACT, Australia. mc2386@cam.ac.uk.; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, United Kingdom. mc2386@cam.ac.uk.
- Source
- Publisher:
Chinese Society of Immunology;; _b Nature Pub. Group Country of Publication: China NLM ID: 101242872 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2042-0226 (Electronic) Linking ISSN:16727681 NLM ISO Abbreviation: Cell Mol Immunol Subsets: MEDLINE - Subject
- Language
- English